CS logo
small CS logo
Marco Confalonieri

Trieste, TS, Italy

About Marco Confalonieri


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of Trieste
2
Total Rows: 1

Clinical Trials at Marco Confalonieri


During the past decade, Marco Confalonieri conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11111100Started TrialsCompleted Trails2020202100.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
2020-03-23
2020-05-10
Completed
173
Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)
2021-04-14
2022-05-04
Completed
690

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Marco Confalonieri" #1 collaborator was "Centro di Riferimento Oncologico - Aviano" with 1 trials as a collaborator and "National Institute for the Infectious Diseases (L. Spallanzani) - Rome" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of Trieste: 2University of Trieste: 2

Created with Highcharts 11.1.0Top CollaboratorsCentro di RiferimentoOncologico - Aviano: 1Centro di RiferimentoOncologico - Aviano: 1National Institute for theInfectious Diseases (L.Spallanzani) - Rome: 1National Institute for theInfectious Diseases (L.Spallanzani) - Rome: 1

Clinical Trials Conditions at Marco Confalonieri


According to Clinical.Site data, the most researched conditions in "Marco Confalonieri" are "ARDS, Human" (1 trials), "Coronavirus Infections" (1 trials), "Covid19" (1 trials), "Severe Acute Respiratory Syndrome" (1 trials) and "Severe Acute Respiratory Syndrome (SARS) Pneumonia" (1 trials). Many other conditions were trialed in "Marco Confalonieri" in a lesser frequency.

Clinical Trials Intervention Types at Marco Confalonieri


Most popular intervention types in "Marco Confalonieri" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Methylprednisolone" (2 trials), "Dexamethasone" (1 trials) and "standard care" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Marco Confalonieri


The vast majority of trials in "Marco Confalonieri" are 2 trials for "All" genders.

Clinical Trials Status at Marco Confalonieri


Currently, there are NaN active trials in "Marco Confalonieri". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Marco Confalonieri, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Marco Confalonieri, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 2Completed: 2